Once-daily umeclidinium/vilanterol 125/25 mcg in COPD: a randomized, controlled study.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Combination long-acting bronchodilator therapy may be more effective than long-acting bronchodilator monotherapy in chronic obstructive pulmonary disease (COPD).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Chest

Title: Chest

ISSN (Electronic): 1931-3543

ISSN (Print): 0012-3692

Publication date (Electronic): May 2014

Volume: 145

Issue: 5

Affiliations

[1 ] Pulmonary Division, Brigham and Women's Hospital, 75 Francis St, PBB Clinics 3, Boston, MA 02115; e-mail: BCelli@copdnet.org.

Article

Publisher Item ID: S0012-3692(15)34589-X

DOI: 10.1378/chest.13-1579

PubMed ID: 24385182

SO-VID: 70990b95-4a4b-4655-a5e8-c999546ae918

History

Data availability:

Comments

Comment on this article

scite_

Cited by 57

See all cited by